Case Reports and Reviews

Palm-Derived Tocotrienols at the Cancer Immunotherapy Interface: PD-L1 Regulation, Tumor Immune Escape, and Emerging Sensitization to PD-1 Blockade

Loso Judijanto

Loso Judijanto

IPOSS Jakarta, Indonesia.

View author publications
PubMed Google Scholar
  10.33425/2693-1516.1083 Published: 25 Oct, 2026
Judijanto L. Palm-Derived Tocotrienols at the Cancer Immunotherapy Interface: PD-L1 Regulation, Tumor Immune Escape, and Emerging Sensitization to PD-1 Blockade. Case Rep Rev. 2026;6(3):98.
Download Citation Abstract PDF